Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
At minimum: A baseline scan before the first dose, a check at 46 weeks during dose escalation, then monthly scans during active therapy, and a comprehensive 6-month outcome review comparing all parameters to baseline
It is in the same family of drugs (incretin-based pharmacotherapy for weight and metabolic disease) but it acts on three receptors rather than one
The goal during titration is not dietary perfection
Adherencia y rutina: El factor ms importante es la consistencia
Retatrutide side effects in clinical trials were predominantly gastrointestinal, consistent with the GLP-1 receptor agonist class
If you're switching between GLP-1s and trying to predict GI tolerance, the practical takeaway is: moving from Wegovy to Zepbound usually feels easier on the gut, while moving from Ozempic up to Wegovy often gets worse before it gets better
